Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
NCT: NCT07189858 · COMPLETED
Brief Summary
This is a Phase 4 multi-center, group-randomized, crossover trial to compare nasal antimicrobial photodisinfection therapy (aPDT) with standard of care for prevention of surgical site infections in patients undergoing major elective, urgent, or emergent surgeries in a hospital setting. The main outcomes are to: 1. compare the efficacy, and 2. estimate the safety of applying nasal (aPDT) before surgery in reducing the incidence of SSIs within the initial 30 days after surgery compared to standard of care (SOC). Participants in the intervention group will receive aPDT prior to surgery on the day of surgery. Participants in the control group will receive standard of care surgical site prevention measures prior to surgery.
Frequently Asked Questions
What is Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada?
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada is a clinical trial registered under NCT07189858. Current status: COMPLETED.
What is the status of NCT07189858?
The current status of NCT07189858 (Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada) is: COMPLETED.
When did Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada start?
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada started on 2026-01-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.